{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:31:38Z","timestamp":1770517898529,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Singapore Immunology Network"},{"DOI":"10.13039\/501100001348","name":"A*STAR","doi-asserted-by":"crossref","award":["F00006"],"award-info":[{"award-number":["F00006"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.imbio.2019.11.003","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T12:00:40Z","timestamp":1573819240000},"page":"151868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["CD39+ regulatory T cells modulate the immune response to carbamazepine in HLA-B*15:02 carriers"],"prefix":"10.1016","volume":"225","author":[{"given":"Meixin","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joey Ming Er","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Chia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ee Chee","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2019.11.003_bib0005","article-title":"Adenosine signaling and the immune system: when a lot could be too much","author":"Antonioli","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imbio.2019.11.003_bib0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.imbio.2019.11.003_bib0015","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2019.11.003_bib0020","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2133.2006.07398.x","article-title":"Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"155","author":"Caproni","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0025","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2019.11.003_bib0030","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2019.11.003_bib0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2019.11.003_bib0040","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2019.11.003_bib0045","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.4049\/jimmunol.1000108","article-title":"Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology","volume":"185","author":"Ernst","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0050","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2217\/14622416.9.10.1543","article-title":"Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations","volume":"9","author":"Ferrell","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.imbio.2019.11.003_bib0055","doi-asserted-by":"crossref","first-page":"16788","DOI":"10.1073\/pnas.0902869106","article-title":"CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease","volume":"106","author":"Friedman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2019.11.003_bib0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0952-7915(99)80014-4","article-title":"Antigen presentation by MHC class I and its regulation by interferon gamma","volume":"11","author":"Fr\u00fch","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4939-8546-3_4","article-title":"Allele frequency net database","volume":"1802","author":"Gonzalez-Galarza","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0070","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0149-2918(01)80132-6","article-title":"Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir","volume":"23","author":"Hetherington","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.imbio.2019.11.003_bib0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jdermsci.2013.10.003","article-title":"Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations","volume":"73","author":"Hsiao","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.imbio.2019.11.003_bib0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.imbio.2019.11.003_bib0085","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2019.11.003_bib0090","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0095","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0026-895X(24)12188-8","article-title":"Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies","volume":"55","author":"Koshiba","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0100","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1007\/s00198-016-3568-9","article-title":"Increased risk of strontium ranelate-related SJS\/TEN is associated with HLA","volume":"27","author":"Lee","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.imbio.2019.11.003_bib0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12016-017-8654-z","article-title":"Current perspectives on stevens-johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Lerch","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0110","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2019.11.003_bib0115","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1074\/jbc.M109.047423","article-title":"Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFoxP3+ regulatory T cells","volume":"285","author":"Mandapathil","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2019.11.003_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-61779-325-7_15","article-title":"Response determination criteria for ELISPOT: toward a standard that can be applied across laboratories","volume":"792","author":"Moodie","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jaci.2009.10.030","article-title":"CD94\/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"125","author":"Morel","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0130","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0135","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis","volume":"123","author":"Nassif","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0140","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3390\/ijms18081737","article-title":"In vitro assays in severe cutaneous adverse drug reactions: are they still research tools or diagnostic tests already?","volume":"18","author":"Porebski","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imbio.2019.11.003_bib0145","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cea.12145","article-title":"In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test","volume":"43","author":"Porebski","year":"2013","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.imbio.2019.11.003_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.03.022","article-title":"CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism","volume":"123","author":"Ring","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2014.12.007","article-title":"The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation","volume":"58","author":"Rissiek","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imbio.2019.11.003_bib0160","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2019.11.003_bib0165","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/cei.12354","article-title":"Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells","volume":"177","author":"Schuler","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1126\/science.8016643","article-title":"Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA","volume":"265","author":"Steimle","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.imbio.2019.11.003_bib0175","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0180","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.it.2016.04.009","article-title":"Regulation of the T cell response by CD39","volume":"37","author":"Takenaka","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/tpj.2013.46","article-title":"Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study","volume":"14","author":"Toh","year":"2014","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.imbio.2019.11.003_bib0190","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI93349","article-title":"Randomized, controlled trial of TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions","volume":"128","author":"Wang","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2019.11.003_bib0195","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2006.12.617","article-title":"Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity","volume":"119","author":"Wu","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imbio.2019.11.003_bib0200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2007-03-081646","article-title":"A2A receptor signaling promotes peripheral tolerance by inducing T-cell energy and the generation of adaptive regulatory T cells","volume":"111","author":"Zarek","year":"2008","journal-title":"Blood"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298519302888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298519302888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:49:44Z","timestamp":1759250984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298519302888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0171298519302888"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2019.11.003","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD39+ regulatory T cells modulate the immune response to carbamazepine in HLA-B*15:02 carriers","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2019.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151868"}}